Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic pain

INTRODUCTION: Genotyping-based treatment decisions may optimize treatment response and minimize adverse drug events (ADEs) in patients with chronic pain. OBJECTIVES: To estimate the financial impact of genotyping-based treatment decisions in patients with moderate to severe chronic pain in a managed...

Descripción completa

Detalles Bibliográficos
Autores principales: Morlock, Robert, Braunstein, Glenn D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2017
Materias:
General Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777678/
https://www.ncbi.nlm.nih.gov/pubmed/29392230
http://dx.doi.org/10.1097/PR9.0000000000000615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777678/
https://www.ncbi.nlm.nih.gov/pubmed/29392230
http://dx.doi.org/10.1097/PR9.0000000000000615

Ejemplares similares